Ganglioside Composition Distinguishes Anaplastic Ganglioglioma Tumor Tissue from Peritumoral Brain Tissue: Complementary Mass Spectrometry and Thin-Layer Chromatography Evidence
Open Access
- 17 August 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (16) , 8844
Abstract
Gangliosides serve as antitumor therapy targets and aberrations in their composition strongly correlate with tumor growth and invasiveness. Anaplastic ganglioglioma is a rare, poorly characterized, malignant neuronal–glial tumor type. We present the first comparative characterization of ganglioside composition in anaplastic ganglioglioma vs. peritumoral and healthy brain tissues by combining mass spectrometry and thin-layer chromatography. Anaplastic ganglioglioma ganglioside composition was highly distinguishable from both peritumoral and healthy tissue despite having five to six times lower total content. Ten out of twelve MS-identified ganglioside classes, defined by unique glycan residues, were represented by a large number and considerable abundance of individual species with different fatty acid residues (C16–C24) in ceramide portions. The major structurally identified class was tumor-associated GD3 (>50%) with 11 species; GD3 (d18:1/24:0) being the most abundant. The dominant sphingoid base residue in ganglioside ceramides was sphingosine (d18:1), followed by eicosasphingosine (d20:1). The peritumoral tissue ganglioside composition was estimated as normal. Specific ganglioside composition and large variability of ganglioside ceramide structures determined in anaplastic ganglioglioma demonstrate realistic ganglioside expression patterns and correspond to the profile of high-grade malignancy brain tumors.Keywords
Funding Information
- Zaklade Adris (13127)
- Sveučilište u Zagrebu (2020)
This publication has 62 references indexed in Scilit:
- Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of SphingolipidomicsChemical Reviews, 2011
- Inhibitors of Glioma Growth that Reveal the Tumour to the Immune SystemClinical Medicine Insights: Oncology, 2011
- Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motilityFEBS Letters, 2009
- Significance of glycosphingolipid fatty acid chain length on membrane microdomain‐mediated signal transductionFEBS Letters, 2009
- Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomainsBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Malignant and benign ganglioglioma: A pathological and molecular study1Neuro-Oncology, 2007
- Human gliosarcoma-associated ganglioside composition is complex and distinctive as evidenced by high-performance mass spectrometric determination and structural characterizationGlycobiology, 2007
- GM3 as a Novel Growth Regulator for Human GliomasExperimental Neurology, 2001
- A procedure for the quantitative isolation of brain gangliosidesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957